These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6347751)

  • 41. Fixed ratio combination of propranolol and bendrofluazide in the treatment of hypertension.
    Pandhi P; Sharma BK; Sharma PL; Wahi PL
    Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):92-4. PubMed ID: 3886568
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical experience with timolol maleate monotherapy of hypertension.
    Bannon JA; Stewart KA; DeLisser O; Schrogie JJ
    Arch Intern Med; 1986 Apr; 146(4):654-7. PubMed ID: 3963944
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Multiclinic evaluation of timolol in the treatment of mild-to-moderate essential hypertension.
    Rofman BA; Kulaga SF; Gabriel MA; Thiyagarajan B; Nancarrow JF; Abrams WB
    Hypertension; 1980; 2(5):643-8. PubMed ID: 6998870
    [No Abstract]   [Full Text] [Related]  

  • 44. [Controlled study of the antihypertensive efficacy of the combination of nadolol and bendroflumethiazide with respect to nadolol alone and placebo].
    Cherchi A; Sau F; Mercuro G; Seguro C; Lai O
    Clin Ter; 1985 May; 113(4):301-6. PubMed ID: 3893868
    [No Abstract]   [Full Text] [Related]  

  • 45. Antihypertensive effect and tolerability of two fixed combination of metoprolol and hydrochlorothiazide followed by a long-term tolerance study with one combination.
    Liedholm H; Ursing D
    Ann Clin Res; 1981; 13 Suppl 30():45-53. PubMed ID: 7027893
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Relation between dose of bendrofluazide, antihypertensive effect, and adverse biochemical effects.
    Carlsen JE; Køber L; Torp-Pedersen C; Johansen P
    BMJ; 1990 Apr; 300(6730):975-8. PubMed ID: 2344503
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of essential hypertension with a combination of propranolol and bendrofluazide.
    Solomon LR; Dawes PM
    J Int Med Res; 1980; 8(1):34-7. PubMed ID: 7358202
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Postmarketing study of timolol-hydrochlorothiazide antihypertensive therapy.
    Bannon JA; Stewart KA; Schrogie JJ; Delisser O
    Clin Ther; 1985; 8(1):76-83. PubMed ID: 3833372
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Timolol maleate and hydrochlorothiazide in control of essential hypertension: use of a fixed combination for once-a-day administration.
    Schwartz FN; Tiffany J
    J Am Osteopath Assoc; 1981 May; 80(9):590-4. PubMed ID: 7019167
    [No Abstract]   [Full Text] [Related]  

  • 50. [Timolol eyedrops in ophthalmological practice].
    Widder W
    Klin Monbl Augenheilkd; 1980 Mar; 176(3):430-40. PubMed ID: 7421007
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Long-term treatment of chronic glaucoma with timolol drops: results after four years (author's transl)].
    Plane C; Boulmier A
    J Fr Ophtalmol; 1981; 4(11):751-6. PubMed ID: 7328270
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antihypertensive therapy with timolol and alpha-methyldopa. A double-blind trial in patients with moderately severe hypertension.
    Lubbe WF
    S Afr Med J; 1976 Feb; 50(9):279-85. PubMed ID: 4898
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Twice-daily 0.2% brimonidine-0.5% timolol fixed-combination therapy vs monotherapy with timolol or brimonidine in patients with glaucoma or ocular hypertension: a 12-month randomized trial.
    Sherwood MB; Craven ER; Chou C; DuBiner HB; Batoosingh AL; Schiffman RM; Whitcup SM
    Arch Ophthalmol; 2006 Sep; 124(9):1230-8. PubMed ID: 16966616
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An eight-week, multicentric, randomized, interventional, open-label, phase 4, parallel comparison of the efficacy and tolerability of the fixed combination of timolol maleate 0.5%/brimonidine tartrate 0.2% versus fixed combination of timolol maleate 0.5%/dorzolamide 2% in patients with elevated intraocular pressure.
    Hatanaka M; Grigera DE; Barbosa WL; Jordao M; Susanna R
    J Glaucoma; 2008 Dec; 17(8):674-9. PubMed ID: 19092465
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Therapy of hypertension with timolol, hydrochlorothiazide and amiloride].
    Hornung RS; Gould BA; Kieso H; Raftery EB
    Fortschr Med; 1983 Mar; 101(10):438-42. PubMed ID: 6840649
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Efficacy of the nadolol-bendroflumethiazide combination in the treatment of arterial hypertension].
    Zecchi P; Bellocci F; Santarelli P; Iannarelli M
    Clin Ter; 1986 Jan; 116(1):19-24. PubMed ID: 2870837
    [No Abstract]   [Full Text] [Related]  

  • 57. Effect of ibuprofen on blood pressure control by propranolol and bendrofluazide.
    Davies JG; Rawlins DC; Busson M
    J Int Med Res; 1988; 16(3):173-81. PubMed ID: 3044869
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Evaluation of the antihypertensive effect and tolerability of nadolol administered alone or in association with bendroflumethiazide].
    Gragnoli G; Righi GA; Turchetti V; Mondillo S; Kristodhullu A
    Minerva Med; 1984 Nov; 75(43):2609-15. PubMed ID: 6392936
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The efficacy and safety of dorzolamide as adjunctive therapy to timolol maleate gellan solution in patients with elevated intraocular pressure. Additivity Study Group.
    Adamsons I; Clineschmidt C; Polis A; Taylor J; Shedden A; Laibovitz R
    J Glaucoma; 1998 Aug; 7(4):253-60. PubMed ID: 9713783
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Practolol and bendrofluazide in treatment of hypertension.
    Galloway DB; Beattie AG; Petrie JC
    Br Heart J; 1974 Sep; 36(9):867-71. PubMed ID: 4609447
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.